Literature DB >> 6379688

Inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.

E C Moore, A C Sartorelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379688     DOI: 10.1016/0163-7258(84)90013-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  4 in total

1.  Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.

Authors:  Kimiko Ishiguro; Z Ping Lin; Philip G Penketh; Krishnamurthy Shyam; Rui Zhu; Raymond P Baumann; Yong-Lian Zhu; Alan C Sartorelli; Thomas J Rutherford; Elena S Ratner
Journal:  Biochem Pharmacol       Date:  2014-08-15       Impact factor: 5.858

2.  Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C).

Authors:  P B Koneru; E J Lien; V I Avramis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

3.  In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine.

Authors:  Anand Joshi; Brian F Kiesel; Nupur Chaphekar; Reyna Jones; Jianxia Guo; Charles A Kunos; Sarah Taylor; Edward Chu; Raman Venkataramanan; Jan H Beumer
Journal:  Cancer Chemother Pharmacol       Date:  2020-09-28       Impact factor: 3.333

4.  Comparison of metabolic pathways of different α-N-heterocyclic thiosemicarbazones.

Authors:  Karla Pelivan; Lisa M Frensemeier; Uwe Karst; Gunda Koellensperger; Petra Heffeter; Bernhard K Keppler; Christian R Kowol
Journal:  Anal Bioanal Chem       Date:  2018-02-23       Impact factor: 4.142

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.